How optimal allocation of limited testing capacity changes epidemic dynamics

Insufficient testing capacity has been a critical bottleneck in the worldwide fight against COVID-19. Optimizing the deployment of limited testing resources has therefore emerged as a keystone problem in pandemic response planning. Here, we use a modified SEIR model to optimize testing strategies under a constraint of limited testing capacity. We define pre-symptomatic, asymptomatic, and symptomatic infected classes, and assume that positively tested individuals are immediately moved into quarantine. We further define two types of testing. Clinical testing focuses only on the symptomatic class. Nonclinical testing detects pre- and asymptomatic individuals from the general population, and a concentration parameter governs the degree to which such testing can be focused on high infection risk individuals. We then solve for the optimal mix of clinical and non-clinical testing as a function of both testing capacity and the concentration parameter. We find that purely clinical testing is optimal at very low testing capacities, supporting early guidance to ration tests for the sickest patients. Additionally, we find that a mix of clinical and non-clinical testing becomes optimal as testing capacity increases. At high but empirically observed testing capacities, a mix of clinical testing and non-clinical testing, even if extremely unfocused, becomes optimal. We further highlight the advantages of early implementation of testing programs, and of combining optimized testing with contact reduction interventions such as lockdowns, social distancing, and masking. (C) 2022 The Authors. Published by Elsevier Ltd.

Automated summary

Insufficient testing capacity has been a critical bottleneck in the worldwide fight against COVID-19. A modified SEIR model was used to optimize testing strategies under a constraint of limited testing capacity. The study found that purely clinical testing is optimal at very low testing capacities, while a mix of clinical and non-clinical testing becomes optimal as testing capacity increases. The study highlights the advantages of early implementation of testing programs and combining optimized testing with contact reduction interventions.